The acute effects of high intensity interval exercise on pulmonary function and exhaled nitric oxide in adults with asthma by Yurach pikaluk, Madison
 
 
 
The Acute Effects of High Intensity Interval Exercise on 
Pulmonary Function and Exhaled Nitric Oxide in Adults with 
Asthma 
 
 
 
 
 
 
A Thesis Submitted to the College of Graduate Studies and Research in Partial Fulfillment of the 
Requirements for the Degree of Master of Science in the College of Kinesiology University of 
Saskatchewan, Saskatoon 
 
 
 
 
 
By Madison Yurach Pikaluk  
Spring 2014  
 
 
 
 
Copyright Madison Yurach Pikaluk, August, 2014. All Rights Reserved 
 
 
 
 
 
 
 
 
 
 
i 
 
Permission to Use 
In presenting this thesis in partial fulfillment of the requirements for a Postgraduate degree from 
the University of Saskatchewan, I agree that the Libraries of this University may make it freely 
available for inspection.  I further agree that permission for copying of this thesis in any manner, 
in whole or in part, for scholarly purposes may be granted by the professor or professors who 
supervised my thesis work or, in their absence, by the Head of the Department or the Dean of the 
College in which my thesis work was done.  It is understood that any copying or publication or 
use of this thesis or parts thereof for financial gain shall not be allowed without my written 
permission.  It is also understood that due recognition shall be given to me and to the University 
of Saskatchewan in any scholarly use which may be made of any material in my thesis.  
Requests for permission to copy or to make other use of material in this thesis in whole or part 
should be addressed to: 
Dean of the College of Kinesiology 
University of Saskatchewan 
105 Gymnasium Place 
Saskatoon, Saskatchewan 
S7N 5B2 
  
ii 
 
Abstract 
 
Introduction: People with asthma suffer from lower fitness levels when compared to their peers. 
The abnormal respiratory response to exercise, known as exercise induced bronchoconstriction 
(EIB), in the majority of people with asthma is a barrier to improving fitness levels. EIB severity 
can be increased with airway inflammation, which can be measured by exhaled nitric oxide 
(eNO). One exercise protocol, high intensity interval exercise (HIIE), may decrease the risk of 
developing EIB in people with asthma. HIIE warm up studies have demonstrated that HIIE is 
feasible and reduces the incidence of EIB in subsequent exercise bouts. HIIE may be ideal for 
people with asthma because it can decrease the duration of high ventilation that can trigger EIB, 
and improve their fitness levels. The purpose of this study is to compare the acute respiratory 
effects of traditional constant workrate exercise to a novel HIIE protocol in adults with asthma.  
Methods: 5 females and 2 males with asthma were recruited to perform two randomly assigned 
exercise protocols: HIIE (30 seconds of 140% the peak workrate and 90 seconds at 20%) and 
constant workrate exercise (CWR) (60% peak workrate). Workrates were determined by a peak 
cardiopulmonary exercise test. Measures of pulmonary function and airway inflammation were 
done pre and post exercise protocols. During exercise protocols, operational lung volumes, heart 
rate, rating of perceived exertion (RPE) was obtained.     
Results: FEV1 decreased significantly in both exercise protocols (HIIE 3.91± 0.65 to 3.33 
± 0.61 vs. CWR 3.90 ±0.50 to 3.09 ± 0.63). eNO measurements decreased after both exercise 
protocols (HIIE 40.4± 34.8 vs. CWR 42.1 ± 36.3. 
Conclusion: FEV1 and eNO findings are similar in HIIE and CWR exercise in adults with 
asthma, therefore, the novel HIIE is a feasible exercise protocol to help improve fitness levels of 
adults with asthma.   
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Chapter 1 
Scientific Framework 
1.1 Context  
People with asthma have lower fitness levels when compared to their peers
1
.   Low 
cardiorespiratory fitness levels not only increase disease risk factors similar to those seen in the 
healthy population, but people with asthma suffer additionally with poor disease control, 
increased  asthma symptoms, and a general decrease in quality of life 
2-4
.      
The benefits of regular exercise are well known for people with asthma; however, exercise 
has the potential to trigger exercise-induced bronchoconstriction (EIB) in a high percentage of 
people with asthma
5,6
.  EIB may be causing people with asthma to refrain from exercising for 
extended periods which puts people with asthma at a greater chance of becoming 
deconditioned
2,4,7-9
. EIB can be avoided while exercising when utilizing appropriate exercise 
modes. 
 
 New exercise protocols need to be designed and evaluated for people with asthma to 
improve their fitness levels without provoking EIB.    
High intensity interval exercise (HIIE) may be an appropriate mode of exercise that will not 
provoke EIB.   HIIE decreases the risk of developing EIB by two key processes: 1) HIIE may 
utilize the refractory period, the period up to 3 hours after exercise where less 
bronchoconstriction occurs, with the use of intervals that may allow people with asthma to 
exercise for longer periods of time
10-12
 and 2) Interval exercise with periods of high and low 
ventilation rates may lead to less chance of developing EIB. During constant work rate exercise, 
high ventilation causes the airway surfaces to cool and dry out and this is thought to lead to 
EIB
13,14
. Interval exercise may lead to less time spent in a high ventilation zone and less chance 
of water loss occurring in the airway surfaces.   
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1.2 Objective 
The objective was to investigate the acute effects of HIIE on pulmonary function, markers of 
inflammation, and respiratory responses during exercise in adults with asthma. The primary 
outcome measure is forced expiratory volume in 1 second (FEV1). The secondary outcome 
measures are eNO, airway resistance (RAW), respiratory rate (RR), ventilation (VE), and 
inspiratory capacity (IC).  
1.3 Literature Review  
1.3.1 Asthma 
There are approximately 300 million people worldwide and 2.3 million Canadians with 
asthma and the prevalence is increasing
15, 16
. Asthma is defined by the Global Initiative on 
Asthma (2008) as:  
“ a chronic inflammatory disorder of the airways in which many cells and cellular 
elements play a role. The chronic inflammation is associated with airway 
hyperresponsiveness that leads to recurrent episodes of wheezing, breathlessness, chest 
tightness, and coughing. . . These episodes are usually associated with widespread, but 
variable, airflow obstruction within the lung that is often reversible either spontaneously 
or with treatment” 
 
The pathogenesis of asthma is complex. There are interactions between host and 
environmental factors that influence the risk of asthma development and the type of triggers
15
. 
The host factors are primarily genetic and the environmental factors include: air pollution, 
exposure to tobacco smoke, and timing of infectious disease exposures during the first year of 
life
15
.  
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The diagnosis of asthma can be established based on the description of episodic symptoms 
and a positive family history of asthma
15
. Further investigations can be done such as pulmonary 
function tests (PFTs), provocation challenge tests, and measures of airway inflammation
15
. PFTs 
can be done to confirm airflow limitation and demonstrate the degree of reversibility
15
. When no 
airflow limitation is present further investigations can include provocation challenge tests. 
Methacholine, mannitol, and exercise challenge tests are all types of provocation challenge tests 
and they measure the level of airway hyperresponsiveness
15
. Direct and indirect measures of 
airway inflammation can be measured with sputum cell counts for inflammatory cells and 
fraction of exhaled nitric oxide levels respectively
17
. 
Asthma disease severity is based on the level of symptoms, airflow limitation, and 
pulmonary function variability
15
. The four categories, in increasing severity, are: intermittent, 
mild persistent, moderate persistent, and severe persistent
15
. The level of severity can change due 
to seasonal variability, exposure to allergens, medication use, and cardiorespiratory fitness 
levels
18,19
.    
Episodes of reversible airway obstruction, i.e. bronchoconstriction, can be triggered by a 
variety of common environmental stimuli such as animal dander, pollen, and exercise
15,20
. 
Common treatment options for adults with asthma include controller medications and reliever 
medications
15
. The effectiveness of controller medications depends on compliance and studies 
have shown that patient compliance is low 
21-23
. Reliever medications include rapid acting 
inhaled β2 agonists and anticholinergics15. Reliever medications are commonly prescribed to 
people with asthma with EIB and they are directed to use prior to exercise as a prophylactic.     
Exercise is another effective treatment option and is gaining evidence in helping with 
disease control
 2,5,24,25
. EIB is seen in the majority of people with asthma, who try to exercise, 
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and can pose challenges in convincing people with asthma that increasing their fitness level may 
be as beneficial as using their medications
11,18
. 
1.3.2 Benefits of Exercise in Disease Management  
People with asthma often suffer from daily to seasonal variability of symptoms
18
. This 
symptom variability is based on a number of factors, including exposure to allergens, viral 
infections, and stress
18
. When pulmonary function is decreased, respiratory symptoms increase 
and individuals with asthma are less likely to be active. One study showed that when respiratory 
function, measured by FEV1, was lower at the start of their day, people with asthma had lower 
physical and social activity later in the day
19
. During times of increased respiratory symptoms, 
people with asthma are less likely to be active. When people with asthma go through repeated 
periods of inactivity, their cardiorespiratory fitness levels can decrease
19
.  This decrease in 
fitness level can lead to further increases in asthma symptoms, poor disease control, and a 
general decrease in quality of life
 2-4
. A vicious cycle of decreasing activity due to an increase in 
symptoms that leads to a decrease in activity, occurs similar to that seen in chronic obstructive 
pulmonary disease
 26,27
. 
There are many benefits of regular exercise in healthy populations
28
. In healthy 
populations, there is evidence to suggest that 150 minutes a week of exercise can decrease the 
risk of developing cardiovascular disease, stroke, hypertension, colon cancer, breast cancer, type 
2 diabetes, and osteoporosis
28
. Along with the above benefits, people with asthma can have 
disease specific benefits from being regularly active and would see their low cardiorespiratory 
fitness levels improve
2,8,9,29
. 
 
Additional disease specific benefits include, decreased asthma 
symptoms,  chance of developing an asthma exacerbation,  risk of developing EIB,  airway 
inflammation,  dyspnea, increased FEV1, and improvements in quality of life
2,4,8,9,24,29
. These 
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benefits are crucial to improving disease control. Periods of inactivity caused by increases in 
asthma symptoms lead to increased risk of deconditioning.  Deconditioning can lead to periods 
of increased asthma symptoms,  increased body mass index (BMI), decreased quality of life , and 
ultimately, increased health care costs
1,2,10,18,30
. 
There are also acute benefits of exercise if EIB is not triggered. A bronchodilatory 
response to exercise is one of the most beneficial
7
. The bronchodilatory response will occur even 
if people with asthma have their lungs bronchoconstricted with methacholine prior to the onset of 
exercise
6
. Despite a strong initial bronchodilatory response, as exercise time and ventilation rates 
increase, pulmonary function begins to decrease and airway resistance increases. This decrease 
in pulmonary function can cause increased asthma symptoms and increase the likelihood of 
dynamic hyperinflation (DH) and increased respiratory muscle work as well
7
. DH is the 
temporary and variable increase in end expiratory lung volume (EELV) above its baseline 
value
31
. Significant DH can be produced with mild bronchoconstriction brought on by 
methacholine challenge testing or during exercise
 32-34
. 
Research into the acute respiratory responses to different exercise protocols for people 
with asthma is needed. Understanding the acute respiratory responses is important in helping 
people with asthma. Determining how different exercise protocols affect people with asthma will 
help in overcoming the initial barrier of getting active. Regular exercise will lead to better 
asthma control and many other benefits previously stated
2,4,8,9,24,29 
. The long term effects of 
regular exercise for individuals with asthma are promising; however, the acute effects of 
different exercise protocols still need to be evaluated in adults with asthma.  Finding an exercise 
protocol that assists them to overcome the initial barriers, particularly EIB, of exercise is crucial. 
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1.3.3 Exercise Induced Bronchoconstriction  
EIB is found in a large majority of people with asthma and in certain athletic populations
11
. 
A positive diagnosis of EIB is still often difficult since exercise testing can only be done in 
exercise physiology laboratories
11
. EIB can be diagnosed by spirometry when FEV1 falls 10% or 
more post exercise
11
. EIB can occur in athletes without a diagnosis of asthma, even though they 
experience AHR and increased inflammation
 
similar to people with asthma
35,36
.  Athletes who 
train and compete in cold and humid air, such as elite cross country skiers, have a higher 
prevalence of EIB than other athletic populations
36-38
.  Factors predisposing certain athletic 
population are unclear but it has been speculated that high intensity exercise could induce or 
promote airway inflammation, either from hyperventilation or from increased airway exposure to 
inhaled allergens or pollutants
39
. Other factors potentially predisposing athletes to EIB could be 
the predominance of the parasympathetic nervous system over the sympathetic
40
.  EIB can be 
found in both people with asthma and athletic populations but the theories to explain the cause of 
EIB in people with asthma have been studied more extensively. 
The three major theories behind the pathogenesis of EIB are osmotic, thermal, microvascular. 
These different theories attempt to explain how normal processes that occur in the airways 
during exercise are leading to an abnormal response of bronchoconstriction. The predominant 
theory is the osmotic theory. The thermal and microvascular theories may also play important 
roles in the development of EIB. All three theories are based on the fact that the cause of EIB is 
not exercise itself, but the increase in ventilation seen as a result of exercise
 
and will be discussed 
in detail below
13,14
. The evidence for ventilation being the key cause of EIB, is demonstrated 
with eucapnic voluntary hypernea (EVH) of dry air
13
. EVH occurs when a subject voluntarily 
hyperventilates and causes bronchoconstriction
13
. Exercise may not be the crucial determinant of 
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the severity of EIB. The severity of airway inflammation, the rate of ventilation reached during 
exercise, and the water content of the inspired air are the crucial determinants
14
.   
The severity of EIB is thought to be related to airway inflammation caused by eosionophils 
through eosinophilic airway inflammation
41
. This type of inflammation can be measured by the 
eNO level present in the airways. These levels can be non-invasively measured with the use of 
chemiluminescence gas analyzers. eNO levels can be measured on a clinical basis to monitor 
airway inflammation but can also be measured acutely for research purposes. People with asthma 
who are experiencing high eNO levels should be aware of its relation to EIB severity, i.e. periods 
of increased airway inflammation can lead to a greater risk of developing EIB. The coupled risk 
of developing EIB and potentially increasing airway inflammation after exercise may lead to an 
increase in asthma symptoms and a decrease in activity levels of people with asthma
10
. Regular 
exercise has shown the ability to reduce airway inflammation overtime
4
. The acute levels of eNO 
measured after exercise to monitor the inflammatory response has been inconsistent in studies 
with participants with asthma and further study is needed
 42-44
. 
The rate of ventilation and the water content of the inspired air that is reaching the lower 
airways are determined by several factors. Inspired air is usually fully conditioned once it passes 
over the nasal mucosa and enters the airways
13
. The lower airways ability to condition inspired 
air is dependent on ventilation rate, water content and temperature of the inspired air, 
temperature of the airway wall, and the availability of airway surface liquid to provide adequate 
humidification
45
. During exercise, breathing patterns change from nose breathing to mouth 
breathing once ventilation increases past 30 L·min
-1 46
. Water loss and cooling of the airways 
occurs during exercise when high ventilation rates are reached.  
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The likelihood of EIB increases with greater ventilation and with dryer, colder inspired 
air
47,48
. There is evidence that interventions that lead to a reduction in airway water loss, such as 
decreasing intensity and duration of exercise, increase the water content of inspired air, and 
breathing through the nose can lead to a decreased severity of EIB
49-51
. A reduction in airway 
water loss may be possible with HIIE since high rates of ventilation are kept short which may not 
lead to the airway surfaces drying.    
Discovering the acute respiratory effects of different exercises protocols on respiratory 
measures is critical to helping people with asthma improve their fitness levels.  It is important to 
identify which exercise protocols lead to less respiratory symptoms, including EIB, to help 
people with asthma engage in more regular physical activity. The benefits of regular aerobic 
training in people with asthma can decrease the severity of EIB. In people with asthma who have 
higher fitness levels there is a less abrupt increase in ventilation during exercise
24
. The greater 
the ventilation rate and the greater number of airway generations required to condition inspired 
air, the greater the likelihood of EIB. A greater number of airway surfaces involved during 
ventilation increases the risk of triggering EIB This fact is particularly important when 
considering the osmotic theory.  
1.3.3.1 Osmotic Theory 
The osmotic theory proposes EIB is caused by increased osmolarity of the airway 
surfaces
13
. Increased osmolarity of the airway surfaces leads to water loss in the airways and the 
release of local mediators, such as histamine
13
. The water loss occurring with high ventilation 
leads to an increase in osmolarity of the airway surface. The increase in osmolarity is postulated 
to lead to the degranulation of airway mast cells. Once degranulation occurs, the inflammatory 
cascade continues with the release of mediators, such as, prostaglandins, leukotrienes, and 
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histamine leading to bronchoconstriction. Along with mast cell degranulation, other 
inflammatory processes can be activated including lymphocytes, eosinophils, epithelial cells, 
neutrophils
13,14 
. Evidence supporting this theory includes the role of leukotrine blockers, the 
location of mast cells, and degranulation of these mast cells. Leukotrienes play a potential role in 
the development of EIB since interventions that use leukotriene blockers are effective in 
reducing EIB 
11
. 
People with asthma have an increased number of mast cells and higher density of mast 
cells and mucous glands in the airway smooth muscle
52
. The increased presence of mast cells and 
mucous glands suggest their involvement in bronchoconstriction
52
. The degranulation of mast 
cells, leading to the release of histamine, is difficult to measure because of histamine’s short half 
life. Histamine can be indirectly measured with markers such as, 9α,11β-prostagladin (PG) F2 . 
PG F2 has been shown to increase with EIB
53
. Other studies have shown that even with a greater 
mast cell density, when people with asthma exercised there was not a cellular influx of histamine 
into the airways
54,55
. Mast cells  may be causing the change in osmolality in the airways which 
may be triggering the release of other inflammatory mediator pathways leading to EIB
54,55
 .  
1.3.3.2 Thermal Theory  
The thermal theory is based on the normal cycle of cooling and rewarming of the airways 
during and after exercise
13
. During exercise, when ventilation rates increase, the airways will 
progressively cool because there is not adequate time to humidify and warm inspired air
56
. This 
progressive cooling of the airways occurs in both healthy adults and people with asthma
56
. Once 
exercise has ceased and ventilation returns to normal the airways rapidly rewarm
14
. Reactive 
hyperemia occurs in the bronchial microvasculature and edema of the airway wall
14
.  
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In people with asthma who experience EIB, this rewarming process happens much more 
rapidly and remains elevated for a longer duration when compared to healthy adults
56,57
. These 
two findings suggest people with asthma have a different microvascular response when 
experiencing EIB. The difference in microvascular response is the basis of the thermal theory. 
Evidence from studies has shown warming of the airway after inhalation of cold, dry air can 
cause EIB
13,48,56
. The thermal theory proposes that the release of local inflammatory mediators is 
not the cause of EIB. The conflicting evidence for the osmotic therory that the degranulation of 
mast cells does occur and is the cause of EIB, suggests the thermal theory may only play a 
limited role in the pathogenesis and development of EIB
52,54,55
.   
1.3.3.3 Microvascular Theory  
The microvascular theory attributes airway microcirculation as the cause of EIB
58
. This 
theory is linked to the remodeling process that occurs over time in people with asthma and the 
changes in bronchial circulation that occur during exercise. The bronchial capillary bed of most 
individuals with asthma is hypertrophied and hyperplastic
58
. The difference in the bronchial 
capillary bed in asthma is due to airway remodeling and the increased production of several 
growth factors that occurs over time. These growth factors lead to an increased number of new 
blood vessels, airway epithelial cells, and an increased secretion of vascular endothelial growth 
factor (VEGF)
59,60
 . 
VEGF has been linked to the development of EIB
61
. VEGF stimulates endothelial cell 
proliferation and increases microvascular permeability. Significant correlations have been found 
between airway microvascular permeability and the severity of EIB
61
.
 
These findings suggest an 
increase in microvascular permeability induces airway wall edema and follows the development 
of EIB. This increase in microvascular permeability is a likely cause of EIB since bronchial 
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circulation within the lungs can influence airway geometry and lead to vascular engorgement, 
capillary leakage and edema formation that can lead to bronchoconstriction
58
.  
The exact mechanisms of EIB are still unknown. The current theories can still offer 
insight into creating new exercise protocols that may help in keep the risk of developing EIB for 
people with asthma. The osmotic theory suggests the airway surfaces are drying out with higher 
ventilation rates and the change of osmolarity is leading to the degranulation of mast cells
13,14
. 
Perhaps the drying of airways and the rest of the process would be less likely to occur if periods 
of high ventilation were shorter. A shorter period of high ventilation could be achieved with 
interval training, where short periods of high intensity, high ventilation, are combined with low 
intensity, lower ventilation. These periods of lower ventilation may give adequate time for 
ventilation and the risk of airway drying to decrease. The thermal theory proposes that when 
ventilation rates increase, the airways cool because there is not adequate time to humidify and 
warm inspired air
56
. This proposed mechanism of triggering EIB can be solved if participants 
breathe warm humidified air; however, this type of environment is not always available
56
. A 
more realistic approach would be to develop an exercise protocol that allows more time to 
adequately warm inspired air. During HIIE, the lower intensity interval may give adequate time 
to do so. The microvascular theory is linked to the remodeling of the pulmonary vasculature that 
occurs over time in people with asthma and the changes in bronchial circulation that occur 
during exercise. This theory seems the least likely to be changed with the mode of exercise since 
changes to the airways are happening chronically versus the acute nature of the Osmotic and 
Thermal Theory.  Further investigations into the acute effects of HIIE are needed to shed light on 
these theories and identify potential mechanisms.   
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1.3.4 Adverse Effects of EIB on Exercise Response  
 People with asthma experience abnormal exercise responses. These abnormal responses 
include EIB, as described previously, and DH. EIB is thought to be caused by the increase in 
ventilation brought on by exercise and is not necessarily caused by exercise itself
1,15
. EIB is a 
well-documented potential side effect of exercise for individuals with asthma. Dyspnea and DH 
are other abnormal respiratory responses that may be occurring in people with asthma during 
exercise.  
Dyspnea, or shortness of breath, is the primary symptom limiting exercise in people with 
chronic obstructive pulmonary disease (COPD) and in some people with asthma
62
.  Those who 
stop due to dyspnea have greater DH and ventilatory constraints
62
. Dyspnea is thought to be 
caused by neuromechanical uncoupling of the respiratory system and dynamic lung 
hyperinflation
62
. In healthy individuals, ventilation rate (VE ) changes in accordance with neural 
central drive
62
. Even though VE increases during exercise, medullary output remains appropriate 
and generally there is no feeling of inspiratory difficulty
62
.  In people with COPD, and possibly 
in people with asthma, DH during exercise constrains tidal volume (VT) expansion and results in 
maximal shortening of the inspiratory muscles
62
. Once VT reaches the inspiratory reserve 
volume (IRV) ceiling, further increases in neural output to the respiratory system do not lead to 
increased mechanical output
62
. This neuromechanical uncoupling may form the basis for the 
perception of respiratory discomfort, which triggers respiratory distress
62
. Dyspnea during 
exercise is associated with progressive mechanical constraints regardless of the presence of DH 
in people with COPD
34
. 
DH has been found in patients with COPD and asthma
31,33
. DH can be measured through 
changes in inspiratory capacity (IC)
 31,33
. DH is strongly associated with the dyspnea, and can be 
produced with provocation or exercise challenges in people with asthma
63-65
. DH is thought to be 
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caused by the development of expiratory flow limitation or the intensity of dyspnea
33,34,66-68
. 
During exercise, breathing frequency and ventilation increase, preventing adequate lung 
emptying during expiration before the next inspiration occurs
33
. DH causes a progressive shift in 
lung volumes towards total lung capacity (TLC)
 33,66-68
. This progressive shift of lung volumes 
towards TLC occurs as the lungs become more hyperinflated, and the work of breathing 
increases as the efficiency of the inspiratory muscles to generate force decreases
66-68
. In a study 
by Kosmas et al. (2004), DH occurred in the majority of participants with asthma even if normal 
spirometry results and no EIB were present
69
. Dyspnea and DH may both be playing an 
important role in the respiratory symptoms experienced during exercise in people with asthma 
even if EIB is not present. If the risk of EIB can be kept low with HIIE it may keep dyspnea and 
the chance of developing DH low as well.    
1.3.5 Asthma and High Intensity Interval Exercise  
HIIE could be ideal for people with asthma to achieve maximal health benefits. HIIE has 
the potential to improve cardiorespiratory fitness levels while keeping the risk of EIB 
development low
7,8
. HIIE training studies have shown that a HIIE swim and land base training 
programs lasting ten weeks reduced the risk of EIB development
8,29
. HIIE training also provided 
a safe and effective exercise treatment option for adults with asthma
8,29
. During swim training, 
participants experienced acute bronchodilatory response that lasted one hour post exercise
8
. After 
the ten weeks of training, exercise capacity was increased and asthma symptoms, including EIB 
were reduced
8
. Land based HIIE training has been shown to be as beneficial as swim based high 
intensity interval training
29
. The majority of participants (68%) in the swim study continued  to 
be physically active and maintained cardiovascular and lung function when follow up was 
conducted three years later
70
.  
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HIIE training studies have been successful in showing adults with asthma are able to 
participate in high intensity interval exercise, and as result, maintain an active lifetstyle
8,29
. These 
training studies did not include all of the acute respiratory effects or suggest a potential 
mechanism for the benefits of HIIE for adults with asthma. Further investigations are needed to 
examine the acute respiratory effects of HIIE.  HIIE warm up exercises have shown the acute 
respiratory effects and potential benefits due to utilization of the refractory period (RF)
 10,12
. The 
RF is the time after the initial bout of exercise during which further exercise will evoke less or no 
EIB
10,12
. In a study by Mickleborough et al (2007) the development of EIB was reduced with the 
use of a HIIE warm up at an intensity of 85-90% maximum heart rate
12
. It appears EIB can be 
blunted in a second bout of exercise if it is done less than 4 hours after the first bout of 
exercise
71
.  The potential mechanism for not developing EIB was the utilization of the refractory 
period, which is seen in approximately 50% of people with asthma.  This mechanism may 
combat the degranulation of mast cells that are thought to occur in the osmotic theory
12,72
. It is 
not known if HIIE warm up RF findings hold true for an HIIE protocol.  Further,  it is also 
unknown if  higher intensity, above 90% predicted maximal heart rate,  interval exercise in 
adults with asthma is tolerable and will utilize the refractory period.  
1.4 Hypotheses   
 I hypothesize 1) that the primary outcome measure, FEV1, will be decreased in both 
constant work rate (CWR) and HIIE exercise protocols and will decrease greater in CWR when 
compared  to HIIE  2) markers of inflammation, eNO and RAW, will decrease and increase, 
respectively, in both CWR and HIIE exercise protocols. eNO will decrease greater and RAW will 
increase greater in CWR when compared to HIIE 3) Respiratory responses during exercise, IC, 
RR & VE, will be increased in both CWR and HIIE exercise protocols and IC will increase 
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greater in CWR when compared to HIIE, whereas, RR and VE will increase greater in HIIE when 
compared to CWR and 4) Markers of inflammation and respiratory responses during exercise 
will be associated to the change in FEV1.   
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Chapter 2 
Methods 
2.1 Participants 
Twelve,  male and female adults over the age of 18 years of age with asthma diagnosed 
by a physician were screened by asking inclusion criteria questions and performing baseline 
testing during day one and two for this study. Seven participants met the inclusion criteria which 
included: a current diagnosis of asthma; tidal breathing methacholine provocation concentration 
to cause a 20% decrease in FEV1 (PC20) ≤ 16 mg/ml; FEV1 > 65% predicted, and no respiratory 
tract infection or allergen exposure for ≥ 4 weeks. Written informed consent was collected from 
all participants prior to data collection and the study was approved by the University of 
Saskatchewan Biomedical Research Ethics Board. (See Appendix A for a copy of the Ethics: 
Certificate of Approval). All testing was done at Royal University Hospital in Saskatoon 
Saskatchewan.  
 
 2.2 Experimental Design  
The research study was conducted using a randomized crossover design and used a 
within subject repeated measures design to assess two different exercise protocols (high intensity 
interval and constant work rate) over time.  Participants were screened for inclusion criteria 
during day one and two of the study. All of the baseline tests were done according to American 
Thoracic Society (ATS) guidelines
73-78
. All study visits were separated by a minimum of 24 
hours and were completed in two weeks to limit potential environmental exposure such as 
changes in air quality and seasonal variability. Day 1 included eNO measurements, spirometry, 
and a methacholine challenge test.  On Day 2, all participants performed full PFTs followed by a 
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maximal cardiopulmonary exercise test.  Randomization of participants occurred on day 3. On 
day 3 and 4, the participants performed pre and post exercise eNO, RAW and TLC measurements, 
followed by one of the two exercise protocols. During exercise, FEV1 and IC measurements were 
performed. FEV1 measurements were performed again at 0, 5, 10, 15, 20, 30 minutes post 
exercise protocols. The study design and measures for each testing day are illustrated below in 
Figures 2.2.1 and 2.2.2.  
Figure 2.2.1 Baseline & Screening Days – Day 1 & 2 
 
 
 
 
 
 
 
 
 
 
Day 1 
eNO 
Spirometry 
PC20 
Day 2 
PFTs  
CPET  
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Figure 2.2.2 Exercise Days – Day 3 & 4 
 
 
2.3 Measures   
2.3.1 Fraction of Exhaled Nitric Oxide (eNO) 
 eNO levels were recorded  to measure airway inflammation. Baseline eNO levels were 
measured on Day 1. eNO levels were measured on exercise days pre and post exercise. eNO 
levels were measured using a chemiluminescence gas analyzer (Niox, Aerocrine Inc., New York, 
NY). Participants performed an inhalation to TLC followed by an exhalation with a constant 
flow rate of 50 ml/sec via a mouthpiece
79
. The procedure was performed in triplicate and 
recorded in parts per billion (ppb). The validity and reliability of this measurement device is high 
(r =0.98, p <0.0001)
80,81
. 
2.3.2 Methacholine Challenge Test (MCT) 
 The MCT was used to determine airway hyperresponsiveness. Baseline MCT PC20 was 
measured on Day 1. The MCT was performed using the standard 2 minute tidal breathing 
challenge as outlined in the current ATS guidelines
75
. The tidal breathing method was performed 
Pre 
Exercise 
eNO 
FEV1 
TLC 
RAW 
During 
Exercise 
FEV1 
IC 
Post 
Exericse 
eNO 
FEV1 (0, 5, 10, 15, 20, 30 min) 
TLC 
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using a Bennett Twin jet nebulizer (Puritan Bennett Corporation, Carlsbad, CA) calibrated to 
deliver an output of 0.13 mg/ml of methacholine. Participants wore noseclips and the aerosols 
were directed to the mouth over a period of 2 minutes via a loose-fitting facemask. Complete 
baseline spirometry was initially performed in triplicate and truncated FEV1 maneuvers were 
performed at 30 and 90 seconds after the completion of each 2 minute inhalation period. The 
next cycle started 5 minutes after the start of the previous cycle. Sterile isotonic saline was first 
to be inhaled followed by doubling doses of methacholine. Concentrations from 0.03 mg/mL to 
64 mg/mL were available. Change in FEV1 was calculated from the lowest post-saline FEV1 and 
lowest post-methacholine FEV1. The challenge continued until FEV1 fell ≥ 17%. PC20 was then 
interpolated or extrapolated from the log dose vs. dose response curve algebraically. 
 2.3.3 Pulmonary Function Tests (PFTs)  
 PFTs performed included: spirometry: lung volumes and capacities: and carbon 
monoxide diffusion capacity (DLCO) tests assessed according to ATS standards
75-77
. The best of 
three trials for each measure was recorded.  
 FEV1 was measured on day 2 for baseline and pre, during, and post exercise on day 3 and 4. 
FVC was measured on day 2 for baseline.  TLC was measured on day 2 for baseline and pre and 
post exercise on day 3 and 4. RAW was measured on day 2 for baseline and pre and post exercise 
on day 3 and 4.  DLCO was measured on day 2 for baseline. IC was measured on day 3 and 4 at 
rest and during exercise. PFTs (FEV1, TLC, RAW, DLCO) were monitored pre and post exercise 
protocols using the Sensormedics, Vmax, which has been shown to be a valid measure
81
.  Lung 
volume measurements (FEV1 and IC) captured during exercise were measured using the 
Parvomedics system and also has been shown to be valid and reliable
82
. 
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2.3.4 Maximal Cardiopulmonary Exercise Test (CPET) 
An incremental exercise test was used to determine cardiorespiratory fitness levels and 
establish participant work rates during exercise protocols. The CPET was performed on Day 2. 
The CPET was performed to the standards of the ATS/ACCP
73
. The test began with a three 
minute warm up of unloaded cycling, followed by ramped increases in work rate until exercise 
tolerance. The work rate increment was individually determined based on their current exercise 
habits whereby individuals who were more active increased at a higher increment. Heart rate and 
ECG were monitored and recorded using a modified 3 lead ECG. Symptoms of dyspnea and leg 
fatigue were individually recorded using the modified Borg scale
83
.  
2.4 Exercise Protocols 
Both exercise protocol, HIIE and CWR, days started with pre exercise measurements of 
eNO and PFTs. Participants then changed into comfortable workout clothes and were fitted with 
a heart rate monitor and fitted to the ergometer. Once seated, the participants were fitted with a 
head piece that would hold the mouth piece. Before the mouthpiece and nose clips were applied, 
the protocol was reviewed for stopping exercise. When the participant was ready, the mouth 
piece and nose clips were applied and then two minutes of resting data was collected while the 
participant rested on the bike. Five minutes of warm up at 50 Watts began after that time. The 
participant was counted down in the last 10 seconds before exercise began. Exercise lasted 20 
minutes or to exercise tolerance and concluded with a cool down. During exercise, participants’ 
ratings of perceived exertion (RPE) for shortness of breath and leg fatigue were individually 
recorded, flow volume loops, and heart rate were recorded at different intervals depending on the 
exercise protocol. When the participant reached exercise tolerance or completed 20 minutes of 
exercise the exercise was stopped and were instructed to cool down. Once the headpiece was 
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removed and the participant had cooled down, they performed post exercise measures for eNO 
and PFTs at 0, 5, 10, 15, 20, 30 minutes post exercise. 
2.4.1 HIIE 
The HIIE consisted of 30 seconds of high intensity exercise at 140% of their peak work 
rate and 90 seconds of low intensity exercise at 60% of peak work rate. Data was collected at the 
end of the each high intensity exercise bout. 
2.4.2 CWR 
Two minutes of resting data was collected while the participant sat on the bike. The 
participant then began their five minute warm up at 50 Watts. The CWR exercise consisted of 
the participants performing at 60 % of their peak work rate as determined by the CPET. Data was 
collected every two minutes.  
The exercise intensities for the protocols were based on the participant’s peak work rate 
established during their maximal CPET done on day 2. Therefore, participants would perform 
equal amounts of work if they were able to complete 20 minutes of exercise in both protocols. 
2.5 Statistical Analysis 
 Using Statistica, a 2 x 2 repeated measures ANOVA was conducted with protocol (high 
intensity interval and constant work rate exercise) and time (pre vs. post or/peak) as factors to 
determine the differences within conditions for the primary outcome measure, FEV1 and 
respiratory responses during exercise, RR, VE and IC. The post exercise values were the lowest 
values within each data set and included FEV1 and IC. The peak exercise values were the highest 
values within each data set and included RR and VE. Tukey’s post hoc analysis was used to 
determine condition differences in the presence of significant main effects. Pearson’s r 
correlation coefficient was used to determine if significant relationships were evident between 
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the change in the primary outcome measure, FEV1, to the change in makers of inflammation, 
eNO and RAW, peak respiratory responses during exercise, VE and RR, and the change in IC 
during exercise 
Using SPSS, a 2 x 2 repeated measures ANOVA was conducted with protocol (high 
intensity interval and constant work rate exercise) and time (pre vs. post) as factors to determine 
the differences within conditions for markers of inflammation, eNO and RAW, and TLC.  
Using Excel, paired t-tests were conducted to assess significance between exercise 
protocols for total exercise time and ratings of perceived exertion. Alpha was set at 0.05 for all 
analyses.  Data are presented as means and standard deviations. 
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Chapter 3 
Results 
3.1 Participant Demographics  
Seven adults with mild to moderate asthma were included in this study and the participant 
demographics are presented in mean (±SD) for sex, age, BMI, VO2 peak in Table 3.1.1.   
Participants had a current diagnosis of asthma, (PC20)≤ 16 mg/ml, FEV1 > 65% and no 
respiratory tract infection or allergen exposure for 4 weeks. Participant pulmonary function 
demographics are presented as mean (±SD) for airway inflammation, pulmonary function, 
airway hypersentivity, total lung volume, and diffusion capacity and can be found in Table 3.1.2. 
Medication use and withholding of medications prior to tests were done according to ATS 
guidelines
21
. 
The participant’s exercise protocol watts, time, and rates of perceived exertion for end of 
exercise shortness of breath and leg fatigue are presented in Table 3.1.3. Participants exercised 
longer in the CWR protocol, p < 0.05. Rating of perceived exertion for shortness of breath and 
leg fatigue did not differ significantly between exercise protocols, p > 0.05.  
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Table 3.1.1 Participant Demographics  
Characteristic Pooled Data Female Male 
Sex 2M:5F   
Age 23.0 ± 3.6 24.4  ±  3.1 19.5  ± 2.1 
BMI 23.6 ± 2.0 24.2  ± 1.9 22.0  ± 1.3 
VO2 Peak (ml/kg/min) 40.4 ± 14.5 33.8  ± 8.4  56.8  ± 14.8 
Mean ± Standard deviation, Body Mass Index (BMI), Male (M), Female (F) 
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Table 3.1.2 Participant Pulmonary Function   
Characteristic  Data 
FEV1 (L) 3.97 ± 0.53 
FEV1 % predicted 106.0 ± 8.8 
eNO (ppb) 47.7 ± 43.7 
FVC (L) 4.81 ± 0.69 
FVC % Predicted 112.0 ± 7.9                                   
TLC (L) 5.95 ± 0.95 
TLC % Predicted 107.0 ± 10.8 
DLCO (mmole CO·min
-1
·kPa
-1
) 28.9 ± 7.0 
PC20  (mg/ml) 3.6 ± 3.5 
Mean ± Standard deviation, Forced Expiratory Volume in 1 
second (FEV1), exhaled nitric oxide (eNO), Forced Vital Capacity 
(FVC), Total Lung Capacity (TLC), Diffusion Capacity (DLCO), 
methacholine provocation concentration to cause a 20% decrease 
in FEV1 (PC20) 
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Table 3.1.3 Participant exercise protocol summary  
  HIIE CWR 
High Interval (watts) 308.0 ± 111.6   
Low Interval (watts) 44.0 ± 15.9   
Constant (watts)   132.0 ± 47.8 
Time (sec) 886.5 ±  255.2 1119.8 ± 153.4* 
RPE End SOB 6.4 ± 2.1 6.4 ± 3.0 
RPE End Leg Fatigue 8.4 ± 1.7 6.9 ± 2.1 
Mean ± Standard deviation, Shortness of breath (SOB), Rating 
of Perceived Exertion(RPE) * denotes significance at p <0.05 
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3.2 Respiratory Responses during Exercise  
3.2.1 Forced Expiratory Volume in 1 second (FEV1) 
There was a significant main effect of time on FEV1 during exercise F (1,18) = 10.611, p 
= 0.00, power = 0.99, η2 =0.64; Figure 3.2.1.1. One subject had a clinical definition of EIB, 
FEV1 decrease greater than 10%, in HIIE exercise protocol. Missing data points occurred during 
exercise for both exercise protocols.  
3.2.2 Respiratory Rate (RR) 
There was a significant main effect of time on RR during exercise, F (1,18) = 32.296, p = 
0.00, power = 1.00, η2 =0.84; Figure 3.2.2.1. 
3.2.3 Ventilation (VE) 
There was a significant main effect of time on VE during exercise, F (1,18) = 34.992, p  
=0.00, power = 1.00, η2 =0.85; Figure 3.2.3.1. Peak VE reached during the CPET did not differ 
significantly with peak VE achieved during the CWR and HIIE exercise protocols (99.7 ± 30.7, 
86.9 ± 37.1, 99.4 ± 35.3, respectively, p >0.05). 
3.2.4 Inspiratory Capacity (IC) 
There was no significant main effect of time on IC during exercise F (1,15) = 0.882, p = 
0.05, power = 0.19, η2 =0.14; Figure 3.2.4.1.  
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Figure 3.2.1.1 – Change in FEV1 for both exercise protocols. Mean values are 
plotted. Values are in litres. FEV1 decreased significantly in both exercise 
protocols over time, p <0.05 High Intensity Interval Exercise (HIIE) and Constant 
Work Rate (CWR). * denotes p <0.05 
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Figure 3.2.2.1 – Change in RR for both exercise protocols. Mean values 
are plotted. Values are in breathes per minute. RR increased significantly over 
time in both exercise protocols, High Intensity Interval Exercise (HIIE) and 
Constant Work Rate (CWR). * denotes p <0.05 
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Figure 3.2.3.1 – Change in VE for both exercise protocols. Mean values are 
plotted. Values are in liters per minute. VE increased significantly in both 
exercise protocols over time. High Intensity Interval Exercise (HIIE) and 
Constant Work Rate (CWR). * denotes p <0.05 
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Figure 3.2.4.1 – Change in IC for both exercise protocols. Mean values 
are plotted. Values are in liters. IC did not change significantly in either 
exercise protocols over time. High Intensity Interval Exercise (HIIE) and 
Constant Work Rate (CWR). * denotes p <0.05 
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3.3 Markers of Airway Inflammation Pre and Post Exercise 
3.3.1 Exhaled Nitric Oxide (eNO) 
There was no significant interaction found between exercise protocols and time on eNO 
levels, F (1,12) = 0.659, p = 0.43 and no significant main effect of exercise type on eNO levels F 
(1,12) = 0.01, p = 0.98. There was a significant main effect of time on eNO levels found, F 
(1,12) = 14.861, p = 0.02; Figure 3.3.1.1.  
3.3.2 Airway Resistance (RAW) 
There was no significant interaction between exercise protocol and time on RAW, F (1,12) 
= 0.03, p  = 0.87, no significant main effect of time on RAW, F (1,12) = 0.927, p = 0.36, and no 
significant main effect of exercise type on RAW, F (1,12) = 0.269, p  = 0.61; Figure 3.3.2.1.  
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Figure 3.3.1.1 - eNO levels vs. time for both exercise protocols. Mean values are 
plotted. Values are in parts per billion.  There was a significant main effect of time 
on eNO levels in both exercise protocols. High Intensity Interval Exercise (HIIE) and 
Constant Work Rate (CWR). * denotes p <0.05 
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Figure 3.3.2.1 – RAW vs. time for both exercise protocols. Mean values 
are plotted. Values are in centimeters of water ·liters
-1
·second
-1
. There 
were no significant differences found between exercise protocols and time. 
High Intensity Interval (HIIE) and Constant Work Rate (CWR).  * denotes 
p <0.05 
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3.4 Operational Lung Volumes 
3.4.1 Total Lung Capacity (TLC) 
There was no significant interaction between exercise protocol and time on TLC, F (1,12) 
= .553, p =0.47,  no significant main effect of time on TLC, F  (1,12) = 553, p =0.47, and no 
significant main effect of exercise type on TLC , F (1,12) = 0.041,  p  = 0.84; Figure 3.4.1.1. 
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Figure 3.4.1.1 – TLC vs. time for both exercise protocols. Mean values are 
plotted. Values are in liters. TLC did not change significantly in either exercise 
protocols over time, High Intensity Interval Exercise (HIIE) and Constant Work 
Rate (CWR). * denotes p <0.05 
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3.5 Correlations  
3.5.1 Markers of Airway Inflammation  
Baseline eNO levels on both exercise days were significantly inversely related to post 
airway resistance, RAW (HIIE r (6) = -0.86, p = 0.01 and CWR r (6) = - 0.75, p = 0.05).  
On the HIIE and CWR exercise day, the change in FEV1 was not significantly correlated 
with the change in eNO, r (6) = 0.70, p =0.08 and  r (6) = -0.38, p = 0.39, respectively.  
On the HIIE and CWR exercise day, the change in FEV1 was not significantly correlated 
with the change in RAW, r (6) = 0.09, p = 0.84 and r (6) = 0.18, p =0.71, respectively. 
3.5.2 Respiratory Responses during Exercise   
On the HIIE exercise day, the change in FEV1 was not significantly correlated with peak 
RR and VE, r (6) = 0.68, p = 0.09 and r (6) = 0.46, p =0.30 respectively.  
On the CWR exercise day, the change in FEV1 was not significantly correlated with peak 
RR and VE, r (6) = -0.31, p = 0.50 and r (6) =  -0.08, p = 0.87 respectively.  
On the HIIE exercise day, the change in FEV1 was significantly correlated with the 
change in IC, r (6) = 0.88, p = 0.01. On CWR exercise day, the change in FEV1 was not 
significantly correlated with the change in IC,   r(6) = 0.14 , p = 0.76.  
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Chapter 4 
Discussion 
4.1  Main Findings  
This study has shown the acute respiratory effects of HIIE when compared to CWR in 
adults with asthma and partially supported our hypotheses. FEV1 did decrease in both exercise 
protocols but did not decrease to a greater degree in the CWR when compared to HIIE; therefore, 
did not support the hypothesis that CWR would lead to an increased risk of EIB when compared 
to HIIE.  The markers of inflammation, eNO and RAW, decreased and remained the same, 
respectively, in both exercise protocols; therefore, did not support the hypothesis that eNO will 
decrease greater and RAW will increase greater in the CWR when compared to the HIIE. 
Respiratory responses during exercise, IC, RR & VE, remained the same for IC and increased for 
RR & VE in both exercise protocols; therefore, did not support the hypothesis that IC would 
increase greater in CWR when compared to HIIE and that RR and VE will increase greater in 
HIIE when compared to CWR. The change in FEV1 during the HIIE exercise protocol was 
correlated with the change in IC; therefore, did not support the hypothesis that markers of 
inflammation and other respiratory responses (change in eNO, change in RAW, peak RR and VE) 
will be associated to the change in FEV1. 
All seven participants were able to perform the novel HIIE (140% peak work rate), with 
no adverse events, such as asthma exacerbations or the need to use rescue inhalers. This study 
has shown similar results to HIIE training studies in people with asthma, that were at a lower 
intensity, 80-90% maximum heart  rate, where no adverse events occurred
8,29
. The finding of no 
adverse events is also similar to HIIE warm studies in people with asthma, which have also been 
done at a lower intensity, i.e. 85-90 % of maximum heart rate
12
. Concrete comparisons of this 
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novel HIIE is difficult since individualized peak work rates were used to determine exercise 
intensity in the present study, whereas prior studies have used maximum heart rate. Further 
research of varying HIIE intensities is needed to determine if there is an ideal HIIE intensity that 
does not cause a decrease in FEV1 for people with asthma.  
FEV1 decreased in both exercise protocols but did not decrease to a greater degree in the 
CWR when compared to HIIE (Figure 3.2.1.1). These findings suggest that although EIB was 
detected, the findings were similar between the HIIE and CWR protocols. Individual results 
revealed that only one subject during the HIIE had a true clinical definition of EIB, a FEV1 
decrease greater than 10% post exercise.  The findings of FEV1 decreasing  is not similar to HIIE 
warm up studies that have shown EIB was less likely to occur after doing a high intensity warm 
up
12
.  This study has also not show similar results to HIIE training studies that have shown a 
bronchodilator effect up to one hour post exercise
8,29
. One possible acute mechanism to explain 
the EIB response could be no activation of the refractory period with interval exercise compared 
to repeated exercise bouts.  Another possible factor could be the HIIE intensity was higher than 
the HIIE training and warm up studies and led to a decrease in FEV1.  
The markers of inflammation, eNO and RAW, decreased and remained the same, 
respectively, in both exercise protocols (Figure 3.3.1.1 & Figure 3.3.2.1). This decrease in eNO 
is similar to those reported in other studies of adults with asthma
86,87
. Increased ventilation and 
pulmonary blood flow may cause the decrease in eNO post exercise
87
. The increased ventilation 
increases the amount of NO to be exhaled from the body, which after exercise causes eNO to 
decrease
87
. Pulmonary blood flow may have led to the decrease in eNO, but it was not measured 
in this study
87
. An increased pulmonary blood flow could have removed NO from the pulmonary 
circulation, causing eNO to decrease. Although eNO did decrease, it does not necessarily reflect 
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a decrease in inflammation but show the potential of an inflammatory process being involved. To 
study the effects of inflammation, blood samples, sputum induction, or 24 hour post eNO levels 
would have been required to measure acute inflammatory markers.   
RAW and TLC were not significantly different from pre to post exercise in either exercise 
protocol. In this study, airway inflammation, measured by eNO, decreased in both exercise 
(Figures 3.3.1.1). The decrease in eNO may explain why no significant changes were seen in 
RAW. In studies of healthy males, RAW was unchanged during exercise and TLC was unchanged 
post exercise
88,89
. In studies with people with asthma and people with COPD, dyspnea and the 
subsequent increase in EELV, and not TLC, appears to be the cause of DH and increases in 
airway resistance
72,90,91
.  Our findings support these prior studies since TLC did not change 
significantly in either exercise protocol and the ICs measurements captured during exercise were 
valid.  
Respiratory responses during exercise, IC, RR & VE, remained the same for IC and 
increased for RR & VE in both exercise protocols (Figure 3.2.2.1, Figure 3.2.3.1, & Figure 
3.2.4.1). The lack of increase in ICs, and therefore no DH expected, could be due to the lack of 
change in RAW in both exercise protocols
72,90,91
. However, the decrease in FEV1 seen in both 
exercise protocols would be likely to produce DH in people with asthma and other clinical 
populations such as COPD
32-34
. This finding is unclear and perhaps with more subjects, the ICs 
would have increased as expected.   
The increase in RR and VE is to be expected due to the increasing metabolic demands of 
the body during exercise. VE did not differ significantly between exercise protocols but since 
total VE was not analyzed, making definite conclusions is difficult. VE was captured in the HIIE 
at the end of the high intensity interval, when VE would potential be the highest. VE would likely 
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be lower if captured during the lower intensity interval or averaged across the entire time period. 
More specific research into how VE is involved is needed to clarify the exact involve of VE.   
Baseline eNO levels were correlated with RAW in the HIIE, but only approached 
significance for the CWR condition (p=0.051). Airway inflammation has been found to correlate 
with airway resistance because RAW is affected by bronchoconstriction and inflammation of the 
airways
41
. Since significance was close for the CWR condition the finding is probably due to low 
participant numbers.   The change in FEV1 was not significantly correlated with the change in 
eNO, change in RAW, peak RR or peak VE.  These findings are not similar to other studies that 
have shown relationships between severity of EIB and eNO
41
. As airway inflammation is 
increased, the severity and likelihood of causing EIB, and seeing a decrease of FEV1 is expected. 
The relationship has also been seen in prior studies between change in FEV1 and change in RAW
6
. 
As FEV1 decreases, and bronchoconstriction occurs, RAW would be expected to increase, 
however, our study did not show this relationship.  The change in FEV1 during the HIIE exercise 
protocol was correlated with the change in IC but not in the CWR exercise protocol. IC was 
expected to increase, and since it did not, the lack of correlation between the change in FEV1 and 
the change in IC in the CWR could be explained by this finding.   
Conclusions on the underlying physiological mechanisms involved in this study are 
difficult, but it may be speculated that changes in airway inflammation may have been involved 
and would support that the EIB seen in this study was caused by the osmotic theory. Since the 
marker for inflammation, eNO, was measured and it is an indirect measure of airway 
inflammation further studies are needed to show conclusive evidence that the EIB mechanisms 
were related to changes in airway surface osmolarity
13,14,56
. Further study would also be needed 
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to rule out that the progressive cooling and rewarming of the airways was not occurring during 
periods of high and low ventilation during the HIIE protocol. 
4.1.1 High Intensity Interval Exercise  
This study is beneficial for people with asthma because there were no adverse events 
associated with either exercise protocol in these participants. This novel HIIE protocol may 
provide people with asthma a type of exercise to try if they are having difficulty exercising due 
to fluctuating asthma symptoms and EIB being caused by CWR. While the long term benefits 
were not examined in this study, HIIE has many potential benefits, discussed below, and has 
been shown in previous studies as a safe way to improving cardiorespiratory fitness while 
keeping the risk of EIB development low in people with asthma
7,8,29
. Other benefits of HIIE in 
healthy participants include being enjoyable, greater lipid metabolism and similar physiological 
remodeling as seen in endurance training 
92-94
. Sprint training, another form of HIIE, has been 
found to be enjoyable when compared to continuous exercise, despite the RPE being higher in 
the HIIE group
92
. When short bouts of anaerobic exercise are coupled with aerobic exercise, 
greater lipid metabolism occurs, which is important for reducing BMI in healthy people
93
. In 
healthy participants, HIIE training induced metabolic adaptations during exercise that are 
comparable to endurance training
94
.  
This study may also benefit people with other respiratory diseases, like COPD, who are 
suffering from similar challenges to improve fitness levels. In people with COPD, interval 
exercise is better tolerated, less breaks are required and better adherence occurs compared to 
continuous exercise
84,85
. The participants in our study were able to tolerate the HIIE protocol and 
were more likely limited by leg fatigue than dyspnea (Table 3.1.3). COPD, like asthma, is an 
obstructive lung disease and comparisons can be made between populations, however, since the 
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participants in this study were relatively young and healthy comparing them to athletes with EIB 
may be more appropriate.  
Athletes with EIB may benefit from this novel HIIE since it is speculated that high 
intensity exercise can increase airway inflammation
39
. HIIE may give athletes with EIB the 
potential to decrease airway exposure to inhaled allergens or pollutants due to intermittent 
periods of lower ventilation, therefore, less potential to promote airway inflammation. HIIE will 
also be more beneficial to certain athletic populations with high rates of EIB, who train and 
compete in a fashion similar to HIIE, i.e. ice hockey, versus endurance athletes, i.e. cross country 
skiers
36,95
.  Further research is needed to draw conclusions between people with asthma and 
athlete populations who suffer from EIB.  
4.2 Limitations  
The small number of participants in this study limits the ability to make concrete 
statistical conclusions, especially when attempting to review individual and gender differences in 
significant and non-significant findings.  With a larger sample size more conclusive evidence for 
HIIE as an exercise option for people with asthma could be found.  Adding participants who are 
known to exhibit EIB would be of benefit to clearly show if either exercise protocol decreased 
the risk of developing EIB.  A healthy control group would be needed to draw any concrete 
conclusions that the findings in this study were only true to people with asthma. For some of the 
measures, during exercise data was missing, therefore, full exercise data could not be analyzed 
and interpreted.  
4.3 Practical Implications and Future Research  
This study provides evidence to support HIIE as another alternative for adults with 
asthma who are trying to increase fitness levels.  HIIE may be what they need to succeed and 
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offer additional benefits when compared to CWR. Other respiratory disease populations, such as 
COPD, who also suffer from decreased fitness levels, may benefit from HIIE.  
Future research should be focused on chronic training studies to determine the long term 
effects and benefits of HIIE on pulmonary function and airway inflammation in people with 
asthma. Future research should also investigate if people with asthma are able to continue to be 
active after the training studies are complete.   
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Chapter 5 
Conclusions 
 
The objective of this study was to compare the acute respiratory effects of traditional 
CWR exercise to a novel HIIE exercise protocol with adults with asthma. The results show that 
adults with asthma are able to perform a novel supra-maximal, 140%, HIIE, with similar 
responses in pulmonary function and markers of airway inflammation outcomes when compared 
to CWR. The results also suggest HIIE is another exercise choice for adults with asthma to 
improve their fitness without compromising their lung function or causing adverse symptoms. 
For people with asthma, improvement in fitness has the potential to decrease risk for developing 
many other chronic health conditions and most importantly, improve disease control.     
Future studies, with greater participant numbers, comparing the long term effects of HIIE 
with CWR exercise protocols on asthma symptoms, quality of life, decreasing the risk of EIB 
development are needed.   
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Appendix A: Consent Form 
 
Participant Information and Consent Form 
 
STUDY TITLE: The Acute Effect of High Intensity Interval Exercise on Pulmonary Function and 
Exhaled Nitric Oxide in Adults Asthmatics 
 
PROTOCOL / STUDY NUMBER: 11-138 
 
PRINCIPAL INVESTIGATOR:  Dr. Scotty Butcher, PhD, School of Physical Therapy, University of 
Saskatchewan, Saskatoon, Saskatchewan, S7N 0W3 (306)966-1711 
          
CO-INVESTIGATORS:  Dr. Darcy D. Marciniuk, MD, & Dr. Don Cockcroft, MD,  Division of 
Respirology, Critical Care, and Sleep Medicine, Royal University Hospital, University of 
Saskatchewan, Saskatoon, Saskatchewan  S7N 0W8  (306)966-8298 
 
  
STUDENT-INVESTIGATORS:  Madison T. Yurach, College of Kinesiology, University of 
Saskatchewan, Saskatoon, Saskatchewan  
 Ingrid M. Worth, College of Medicine, University of Saskatchewan, Saskatoon, Saskatoon 
 
CONTACT PHONE NUMBER: (306) 966-1711 
 
We would like to invite you to take part in a research study that is being run at the Respiratory 
and Integrative Clinical Exercise Physiology laboratory in Royal University Hospital. Please take 
the time to read this consent form and if you wish, discuss it with friends, relatives or your 
study doctor.  This consent form may contain words that you do not understand.  Please ask the 
study doctor or the study staff to explain any words or information that you do not clearly 
understand, or if you would like more information. Take as much time as you need to decide 
whether or not to take part.  Your participation in this study is entirely voluntary, so it is up to 
you to decide whether or not to take part.  If you decide to participate, you are still free to 
withdraw at any time and without giving any reasons for your decision. If you do not wish to 
participate, you will not affect your care or academic standing.   
 
Introduction 
You are being invited to take part in this research study because you are 18 – 45 years of age 
and either have or have never been diagnosed with asthma.  We are expecting to enroll 15 
asthmatics and 15 non asthmatics in this research study. Please feel free to ask the study 
investigator or research staff any questions that will help you understand the study and what 
you are expected to do.  Before you agree to take part in this study, you may take this 
information home and discuss it with a family member or your family doctor. 
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Purpose of the Study 
We are studying the nature of breathing limitations with two different exercise protocols in 
healthy and asthmatic adults. Recent evidence suggests that asthmatics have more breathing 
difficulties than their healthy peers during the traditional constant work rate exercise. By using 
a different high intensity interval exercise protocol we may be able to reduce breathing 
limitations for asthmatics. 
  
Study Visits and Procedures 
Main Study: 
The study doctor or staff will carefully explain all procedures and you should ask whenever you 
need more information. You must provide consent to participate in this study before you 
perform any study-related procedures.  You will be scheduled to attend the laboratory on 6 
occasions over a period of up to 4 weeks.  These scheduled visits will be one to two days apart.  
At each visit you will be required to perform breathing and exercise tests.  You will be asked to 
avoid consuming caffeine-containing products (e.g. coffee, tea, chocolate) for 4 hours and 
strenuous activity (e.g. cycling, running) for 12 hours before visits.  A normal mixed diet, as 
outlined by the Canadian Food Guide, should be eaten prior to your visits to the laboratory.  
These dietary controls are important in allowing us to obtain valid experimental results.  You 
will be asked to not use short-acting B2-agonists (ie. Ventolin, Bricanyl) for 4 hours before each 
visit, inhaled anitcholinergics (ie. Atrovent) for 10 hours. You may not be on many of these 
medications, but if you feel the need to use any of these medications within these time periods 
you should use them without hesitation, and we will just re-schedule your visit.  
 
As a participant in the study, you will be asked to complete the following procedures: 
  Visit 1:  You will be asked to attend a screening visit, which will last about 1.5 hours.  At 
this visit the study staff will check whether you are suitable for the study:  you will be asked 
some questions about your medical history and the medicines you are using; you will have a 
general health check up which will include blood pressure measurements. You will be asked to 
some breathing tests and undergo a methacholine challenge test. This is a standard, widely 
used test, which assists researchers and doctors in the assessment and severity of airway 
responsiveness.  
 
Visit 2:  This visit will last about 1 hour. During this visit you will be asked to do some breathing 
tests and you will be asked to exercise on a stationary bicycle for as long as you can.  While you 
are cycling, it will become increasingly harder to cycle – it will feel similar to cycling up a hill 
that gradually gets steeper and steeper.  We will measure your breathing by having you breathe 
through a mouthpiece while wearing nose clips.  We will ask you to breathe deeply periodically 
throughout the test.   
 
Visit 3 and 5:  (tests will be performed in random order). These visits will last approximately 3 
hours each. You will be asked to perform two exercise tests on a stationary bicycle for 20 
minutes each or till you cannot go any longer. One test will be a constant resistance exercise 
tests and the other exercise test will be a high intensity interval trial. The high intensity of the 
interval trial will consist of alternating periods of high and low intensities. During both visits we 
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will measure your breathing with a mouthpiece and nose clips.   We will ask you to breathe 
deeply periodically throughout the test.  During each test, we will measure your oxygen levels 
and heart rate.  You will also be asked to pick a number on a scale that describes how 
breathless and how fatigued you feel.  Prior to each test you will perform breathing tests similar 
to those performed on Visit 1.   
 
 
In order to measure breathing mechanics, we will ask to insert a balloon catheter through your 
nose into your esophagus.  You will be asked to sit in a comfortable chair and the back of your 
nose and throat will be sprayed with a local anesthetic (similar to the anesthetic used when you 
have dental work).  A balloon catheter, which is much like a thin piece of spaghetti, will then be 
passed through the nose and swallowed into your stomach by sipping water through a straw.  
The catheter will be withdrawn slightly to position it accurately and it will be held in place by 
small bits of tape attached to your nose and cheek.   
 
Visit 4 and 6: These visits will be 24 hours after the exercise trials  (i.e. third and fifth visits 
accordingly). The visits will last about 30 minutes and exhaled nitric oxide and breathing tests 
will be performed.  
 
Sub-study: 
In addition to the above procedures, participants who have been diagnosed with asthma will be 
asked to participate in a sub-study involving the use of standard, preventative bronchodilation 
therapy on the responses and exercise protocols above.  You may choose to participate in the 
main study and not this sub-study.  This sub-study will involve 2 additional visits to the 
laboratory.  These visits will follow the exact same procedures as Visits 3 and 5 above, with the 
exception that participants will be asked to inhale a common fast acting bronchodilator 
(Ventolin/Salbutamol) 20 minutes prior to the exercise tests.  On one of the visits, participants 
will be asked to perform the high-intensity interval protocol and on the other visits, participants 
will be asked to perform the constant work rate protocol.  These 2 extra visits will be 
randomized with Visits 3 and 5 of the main study.  These two extra visits will not require the 
two visits subsequent to the exercise visits (ie. Visits 4 and 6 of the main study). 
 
Breathing Tests:  You will be asked to perform several routine lung function tests that are 
widely used in the assessment of lung function.  For most of the tests, you will be asked to 
breathe through a rubber mouthpiece with your nose clipped.  Each test will be repeated 3 – 4 
times until results are consistent.  During one series of tests, you will be asked to breathe all the 
way in before blowing out for as long as you can:  in one set of tests you will blow all the way 
out slowly, in the other set of tests you will blow out as hard and as fast as you can.  In another 
test, you will gently “pant” through a mouthpiece while sitting inside a closed chamber; the air 
during panting will at first move through the mouthpiece, then will be blocked for a few 
seconds while you make small efforts to pant with no movement of air.  During another 
breathing test you will be asked to remove your nose clips and take a deep breath in and blow 
out at a constant speed into a machine that will measure your exhaled nitric oxide levels.  
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Exercise Tests:  While breathing through a rubber mouthpiece wearing nose clips, you will be 
asked to perform several exercise tests consisting of cycling to an endpoint of fatigue, shortness 
of breath or any other discomfort for which you may need to stop.  If, at any time during the 
exercise tests, you do not wish to continue for any reason, you may stop exercising voluntarily.  
During and after the testing, you will be asked to rate your breathlessness on a simple 
questionnaire.  At the end of each exercise test, you will be asked the reason you stopped the 
exercise and to choose phrases from a list which best describes your breathlessness and leg 
fatigue. 
 
Methacholine Challenge:  This is a standard test that assists researchers and doctors in the 
assessment and severity of airway responsiveness. Methacholine is a substance that will cause 
your airways to narrow, i.e. bronchoconstrict.  You will begin the challenge perform breathing 
tests described above at least three times. Next you will inhale methacholine by having a 
facemask placed over your nose and mouth for 2 minutes while you breathe normally.  The 
concentration of methacholine you inhale will increase until your forced expiratory volume in 1 
second decreases 20%. During this test you may feel chest tightness, shortness of breath or 
cough; however, these symptoms are short-lived and can be resolved on their own or after 
treatment with a bronchodilator.  
 
Exhaled Nitric Oxide Measurement:  The measurement of eNO allows researchers and doctors 
in the assessment and severity of airway inflammation. The higher the eNO level the greater 
the amount of inflammation. This test will require you to take a deep breath in followed by 
breathing into a small portable machine at a constant rate until your lungs are empty. This test 
will be repeated 3 times.   
 
Benefits Associated with the Study 
You will not have a direct personal benefit from participation in this study, but you will be 
contributing to our understanding of how asthmatics experience breathing limitations.  In 
addition, you will be provided with your individual results if requested.  
 
Potential Risk and Discomforts 
As with any type of strenuous activity, there is a very small risk that the stress of performing 
exercise will cause heart rhythm abnormalities, chest discomfort or light headedness.  People 
with a history or presence of significant cardiac (heart) disease or heart rhythm disorders 
should not participate in this study.  The study doctor may decide that you should not perform 
the exercise tests, based on information in your medical history.  It is important that you let 
the study investigator or staff know if you have ever been advised not to participate in 
strenuous activities.  It is also important that you report any pain, discomfort, fatigue or other 
symptoms that you might have during the exercise test to the physician in attendance.   
 
During the performance of the breathing tests, major discomfort is unusual.    However, you 
may experience mild light-headedness or breathlessness, or you may cough or wheeze at the 
end of some of the breathing tests, but these sensations subside as soon as the test is stopped 
for a few moments.  People who have had a recent heart attack, recent eye or abdominal 
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surgery, or any history of coughing up significant amounts of blood in the previous 6 months 
will not be asked to undergo these tests.  Insertion of the balloon catheter presents minor risks 
which could include: discomfort on insertion of the catheter, minor nasal trauma (nose bleed), 
gagging or vomiting. 
 
Risks of the study are related to the measurements being performed (see above).  Risks and 
discomforts will be minimized by preliminary screening and examination, by observations made 
throughout the study, and through close access to emergency equipment and medical 
personnel.  You will be carefully monitored throughout testing and a physician will be 
immediately available in case problems should arise.  All tests will be performed by staff who 
are trained to deal with problems that may arise.  At any time during the study, it is important 
that you tell the study doctor if you feel unwell or experience any problems or side effects.  
It is usual to experience some degree of muscle discomfort during the tests described above.  
This discomfort should be temporary.  Your muscles may feel sore for a couple of days after 
each test.  This soreness is expected due to the testing procedures and should subside quickly.  
If you are concerned about the amount of soreness, let the study staff know. 
 
Methacholine is routinely used in clinical practice and in research for assessing airway 
responsiveness. Methacholine is a registered product (Provocholine®) and as such is approved 
for use in Canada by the Therapeutic Products Directorate of Health Canada. Possible side 
effects from inhaling methacholine include coughing, chest tightness, shortness of breath or 
wheezing. Rarely, symptoms may include headache, itching, throat irritation or light 
headedness. Any symptoms are usually very quickly relieved after stopping the test or with the 
use of a bronchodilator. You should let the study staff and/or doctor know if you experience 
any of these symptoms during this test.  
 
Ventolin is routinely used in clinical practice and in research for achieving bronchodilation in 
patients with airway constriction.  Ventolin is a registered product (Salbutamol®) and as such is 
approved for use in Canada by the Therapeutic Products Directorate of Health Canada.  Possible 
side effects from inhaling ventolin include coughing, difficulty sleeping, dry or irritated throat, 
faster heartbeat (usually temporary), flushing, headache, irritability, nausea, nervousness, 
restlessness, tremor (shakiness), or viral infections of the nose and throat (fever, sore throat, 
runny nose).  Any symptoms are usually temporary and very quickly relieved. You should let the 
study staff and/or doctor know if you experience any of these symptoms during your visits. 
 
If you are pregnant or are currently breastfeeding, you will not be allowed to participate in this 
study. You should also avoid becoming pregnant during this study. Although methacholine 
challenge testing are not contraindicated during pregnancy or while breastfeeding it is an 
unnecessary exposure and as such will be avoided. A urine pregnancy test will be conducted at 
the start of each treatment period to ensure you are not pregnant. 
 
Research-Related Injury 
There will be no costs to you for participation in this study.  You will not be charged for any 
research procedures.  In the event that you become ill or injured as a result of participating in 
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this study, necessary medical treatment will be made available at no additional cost to you.  By 
signing this document you do not waive any of your legal rights. 
 
Voluntary Participation and Withdrawal 
Your participation in this study is voluntary and you may choose not to participate or withdraw 
from the study, at any time, without penalty or loss of benefits to which you are otherwise 
entitled.  If you do not wish to participate or if you withdraw from the study, neither your 
current nor future medical care will be adversely affected.  If you agree to participate in the 
trial, the study staff will ensure, with your agreement, that your family doctor is informed about 
your participation.  The study investigator or doctor may also remove you from the study at any 
time if it is decided that it is not in the best interest of the study and/or your health to continue, 
or if you do not follow the study staff’s instructions. 
 
If you develop a problem that requires medical attention, you should seek emergency medical 
treatment, and then contact the study doctor immediately. 
 
Payment to Participants 
You will not be paid for taking part in the study. There will be no charge to you for any tests 
done as part of the study.   
 
Confidentiality 
Your confidentiality will be respected.  No information that discloses your identity will be 
released or published without your specific consent to the disclosure.  However, research 
records identifying you may be inspected in the presence of the Investigator or his or her 
designate by representatives of University of Saskatchewan Research Ethics Board for the 
purpose of monitoring the research. However, no records, which identify you by name or 
initials, will be allowed to leave the Investigators' offices.  
 
The results of this study may be presented in a scientific meeting or published, but your identity 
will not be disclosed. 
 
Further Information 
You may contact Dr. Scotty Butcher, at (306)966-1711 for side effects, questions, or concerns.  
For medical emergencies, please go to a hospital emergency room.  You have the right at any 
time to request information from the study staff about your condition. You may also request 
that any other person, including your personal doctor, be given this information and a copy of 
this form.     
 
The study has been reviewed and approved by the University of Saskatchewan Biomedical 
Research Ethics Board.  They are responsible for safeguarding the safety, rights and well-being 
of human participants participating in research studies.  For additional information regarding 
your rights as a research participant or concerns about the study, contact the Chair of the 
Biomedical Research Ethics Board, c/o the Ethics Office, University of Saskatchewan at 
(306)966-4053.   
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If you have any questions during the study, or if you experience any side effects, please contact: 
 
Dr. Scott Butcher (Principal Investigator):  (306) 966-1711 
Please take a copy of this form home with you. 
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The Acute Effect of High Intensity Interval Exercise on Pulmonary Function and Exhaled Nitric 
Oxide in Adults Asthmatics 
 
CONSENT FORM 
 
I have read and I understand the information presented in this form.   
I have had the purpose, procedures and technical language of this study fully explained to me.  I 
have been given sufficient time and opportunity to consider the above information, to inquire 
about details of the study and to decide whether or not to participate. 
Having read all pages of this information and consent form and understanding the 
requirements of the study, my signature below indicates that I voluntarily consent to 
participate in this study. 
I understand that I will receive a copy of this information and consent form. 
 
Please check the appropriate statement to indicate your decision:   
                My family physician can be informed about my participation in this study, and, if 
required, consulted regarding my health and treatment. 
      or 
                My family physician cannot be informed about my participation in this study, and, if 
required, consulted regarding my health and treatment. 
 or 
________ I do not have a family physician. 
 
 
_____________________________________________ 
Participant Name (print name) 
 
 
_____________________________________________  
Signature of Participant      Date 
 
 
I, or one of my colleagues, have carefully explained to the participant, the nature of the above 
research study.  I certify that, to the best of my knowledge, the participant clearly understands 
the nature of the study and the demands, benefits and risks involved in participating in the 
study. 
 
 
_____________________________________________ 
Investigator (or Designee) Name (please print) 
 
 
_____________________________________________ _________________ 
Investigator (or Designee) Signature     Date 
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Appendix B: Day 1 Data Sheet 
 
Name:          
Height:     Weight(kg):    
Gender:  M  -  F  
DOB(Da/Mo/Yr)  
 
Medical Background:  Healthy    -   Asthma  
Exclusion criteria for asthmics: 
- tidal breathing methacholine provocation concentration to cause a 20% decrease in FEV1 
(PC20) > 16 mg/ml 
- FEV1 < 65% predicted 
- Respiratory tract infection or allergen exposure for ≥ 4 weeks 
 
Exclusion criteria for both groups include: 
- chronic or acute cardiac, metabolic, neuromuscular illness 
- musculoskeletal illness or injury that would limit their ability to perform heavy exercise 
 
Medications & Dosages 
 
 
 
 
Exercise Background (aerobic and strength) 
 
 
Have you done any of the following….. 
 No strenuous activity within 12 hours of test 
 
 No alcohol, caffeine within 4 hours of test 
 
 No short acting B2-agonists (ie. Ventolin, Bricanyl) for 4 hours before each visit 
 
 No inhaled anticholinergics ( ie. Atrovent ) for 10 hours  
 
 
eNO (ppb)    (within 10%) 
1    2    3    Avg:    
 
Baseline Spirometry (attach printout) 
FEV1    FEV1          FEV1    
% Pre    % Pre                              % Pre    
Methacholine – time inhaled = 2min 
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Concentration 30 sec FEV1 90 sec FEV1 % ↓ FEV1 
Diluent    
    
    
    
    
    
    
    
    
    
PC20 =  
 
Calculations 
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Appendix C: Day 2 Datasheet  
 
Pulmonary Function Tests – Best Values 
FEV1  
% Pred   
TLC  
RV  
DLCO  
DLCO/VA  
RAW  
Print out PFT 1 page  
 
VO2 Max Test 
Max Watts VO2 Max   ________ 
RPM             ________ 
Print out Cardiopulmonary Exercise Test Results  
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5 min 50 W warm up protocol. 
   Ex Time Blood Pressure RPE IC  Heart Rate 
    SOB Legs (Ö)   
RESTING           
            
0:00           
0:30           
1:00           
1:30           
2:00           
2:30           
3:00           
3:30           
4:00           
4:30           
5:00           
5:30           
6:00           
6:30           
7:00           
7:30           
8:00           
8:30           
9:00           
9:30           
10:00           
10:30           
11:00           
11:30           
12:00           
12:30           
13:00           
13:30           
14:00           
14:30           
15:00           
            
ENDING           
Why did you stop? 
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Appendix D: CWR Data Sheet 
CWR  
 
 
Name: _____________________ Subject #:____________ 
   
 
  
Age: ____________ Weight:________      Height: _____ 
       OW 1 min WU 
 
60% of Max Watts VO2max:_________ 
      
Time 
RPE 
IC (√ ) Heart Rate 
SOB Legs 
Resting         
          
0:00         
0:30         
1:00         
1:30         
2:00         
2:30         
3:00         
3:30         
4:00         
4:30         
5:00         
5:30         
6:00         
6:30         
7:00         
7:30         
8:00         
8:30         
9:00         
9:30         
10:00         
10:30         
11:00         
11:30         
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12:00         
12:30         
13:00         
          
END 
        
Why did you stop?       
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Appendix E: HIIE Datasheet 
 
       HIIE 
 
    
        Name: 
_______________________________ 
Subject #: 
____________________ 
 
         20% Max Watts VO2max: _______     140% Max Watts of 
VO2max:_______ 
5 min unloaded warmup in protocol. 
  
Ex Time Blood Pressure RPE   IC  
Heart 
Rate 
    SOB Legs ()   
RESTING           
            
0:00           
0:30           
1:00           
1:30           
2:00           
2:30           
3:00           
3:30           
4:00           
4:30           
5:00           
5:30           
6:00           
6:30           
7:00           
7:30           
8:00           
8:30           
9:00           
9:30           
10:00           
10:30           
11:00           
11:30           
12:00           
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12:30           
13:00           
13:30           
14:00           
14:30           
15:00           
15:30           
16:00           
16:30           
17:00           
17:30           
18:00           
18:30           
19:00           
19:30           
20:00           
ENDING           
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Appendix F: Day 3 and 4 Datasheet 
Day 3 or 4 – Exercise Days  Subject ID: 11-138 
Date:                                                                Location 
 
□ No strenuous activity within 12 hours of test 
□ No alcohol, caffeine within 4 hours of test 
□ Any medications? Yes  No 
□ If yes, which? When? 
 
1. Baseline eNO (ppb) (within 10%) 
1     2    3   avg 
2. Spirotmetry  
FEV1    FEV1    FEV1 
% pred    %pred    %pred  
FVC    FVC    FVC 
3. Plethysmography  
TLC       RAW  
PRINT OUT PFT ALL TRIALS AND 1 PAGE PFT REPORT  
4. ECG Leads on  
 
5. Balloon Insertion  
 
 
6. Exercise  CWR     HIIE 
a. 2 min resting data 
b. 5 min warm up  
c. Exercise 20 min or tolerance 
d. 5 min cool down  
 
7. Balloon out  
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8. Post exercise  
eNO (ppb) 
1    2   3   avg 
Time 
Post 
Exercise 
(min) 
Time 
(h:min) 
FEV1 
(L) 
FEV1 FEV1 TLC  RAW 
0        
5       
10       
15       
20       
30       
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Appendix G: During Exercise Graphs 
 
 
Figure A-1: FEV1 vs. time up to 10 minutes and end for both exercise 
protocols. Mean values are plotted. No significant differences seen in FEV1 
between exercise protocols at any time point, p >0.05. Values are in liters. High 
Intensity Interval Exercise (HIIE) and Constant Work Rate (CWR).  
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Figure A-2: IC vs. time up to 10 minutes and end for both exercise 
protocols. Mean values are plotted. Values are in litres. No significant 
differences seen in ICs between exercise protocols at any time point, p>0.05. 
High Intensity Interval Exercise (HIIE) and Constant Work Rate (CWR).  
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